There has been so much to worry us in recent weeks but now some good news on the horizon , with the advent of a new clinical trial which will combine the use of Evusheld with vaccinations for immunocompromised patients. We speak to the trial’s lead, Mark Tuthill and the panel responds to some of your questions and concerns.Hope you find it useful!